HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Brookstone Capital Management's Holding History (CIK: 0001599584)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 61,601 Value ($000) $3,931 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 60,587 Value ($000) $2,897 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 60,587 Value ($000) $3,468 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 61,697 Value ($000) $3,378 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 61,710 Value ($000) $2,510 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 60,308 Value ($000) $2,229 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 60,336 Value ($000) $2,160 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 60,415 Value ($000) $2,212 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 60,415 Value ($000) $2,175 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 60,310 Value ($000) $3,346 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 60,310 Value ($000) $2,569 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 60,345 Value ($000) $3,125 Avg Close $43.25 Range $36.95 - $48.58
Q1 2022
Shares 60,310 Value ($000) $2,496 Avg Close $35.62 Range $31.36 - $42.33
Q4 2021
Shares 60,310 Value ($000) $2,249 Avg Close $37.33 Range $31.79 - $41.20
Q3 2021
Shares 60,310 Value ($000) $2,225 Avg Close $41.81 Range $37.80 - $46.62
Q2 2021
Shares 60,310 Value ($000) $2,708 Avg Close $44.26 Range $38.65 - $51.57